Instituto Ecuatoriano de Enfermedades Digestivas
40
4
4
20
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 40 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 20 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (40)
Endoscopic Ultrasound Shear Wave for Liver Fibrosis in MASLD Patients: The RUMIPAMBA Trial
Role: lead
Cholecystectomy vs EUS-guided GBD With Stone Removal
Role: lead
Motorized Fine Needle Biopsy vs Standard Needles
Role: lead
Artificial Intelligence vs Endoscopist Identification in EUS Normal Anatomy
Role: lead
Safety and Efficacy of a Novel Flexible Bipolar in POEM
Role: lead
Detective Flow Imaging Endoscopic Ultrasonography in Subepithelial Lesions
Role: lead
EUS Share-wave in Patients With Liver Cirrhosis
Role: lead
Computer-aided Detection During Screening Colonoscopy
Role: lead
Endoscopic Ultrasound Radiofrequency Ablation for GISTs
Role: lead
CAD EYE Detection of Remaining Lesions After EMR
Role: lead
Holographic Screens as a Replacement of Monitors During GI Endoscopies
Role: lead
AI Guidance for Biopsy in Suspected Cholangiocarcinoma
Role: lead
Hyaluronic Acid in Patients With Gastroesophageal Reflux Disease
Role: lead
Artificial Intelligence for Digital Cholangioscopy Neoplasia Diagnosis
Role: lead
Plastic vs Biodegradable Pancreatic Stent in Post-ERCP Pancreatitis Prevention
Role: lead
Computer-aided Detection During Screening Colonoscopy (Experts)
Role: lead
Virtual Chromoendoscopy With Magnification in Coeliac Disease.
Role: lead
Confocal Laser Endomicrospy in Colonic Diverticular Disease
Role: lead
EUS Shear Wave for Solid Pancreatic Lesions.
Role: lead
Endoscopic Ultrasound (EUS) Artificial Intelligence Model for Normal Mediastinal and Abdominal Strictures Assessment
Role: lead